Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies

NCT02021903 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Parkinsonian Disorders

Interventions

OTHER: V1: HGPO + meal and V2: placebo + meal
OTHER: V1: placebo 75mg + meal and V2: HGPO 75mg + meal

Sponsor

University Hospital, Toulouse

Collaborators

[object Object]